BRAND ACCELERATION

Red Team Associates looks at both the customer and non-customer viewpoint.  We identify barriers to adoption, allowing us to reframe/reposition a product and change the targeting and segmentation a client utilizes.

Below are a few examples of life science companies and products we have helped accelerate.

Vyvanse.png

Situation

  • Vyvanse was underperforming

  • 8% market penetration

  • Brought in by President to help accelerate Vyvanse penetration
     

Activities

  • Performed a 360⁰ assessment of the product’s commercialization strategy 

  • Developed a revised commercial strategy 

    • Positioning

    • Targeting

    • Messaging

Impact

  • Revised commercial strategy increased Vyvanse market share by 5 points in 18 months

Linzess.png

Situation

  • Linzess (medication for IBS‑C and CIC) was underperforming relative to financial expectations

  • Brought in by major investor to help accelerate Linzess penetration and the impact DTC would have

Activities

  • Interviewed prescribers and non-prescribers

  • Spoke with patients both with IBS-C on and off Linzess

Impact

  • Projected impact DTC would have on Linzess sales at the time

  • DTC delivered 30% growth, which was within 5% of what RTA projected
     

Valtoco.png

Situation

  • Company introducing intranasal Diazepam for rescue treatment of epilepsy

  • Product launched during Covid-19

  • Larger competitor, similar product launched 5 months earlier

Activities

  • Interviewed patients, caregivers, physicians, and school nurses

  • Performed RADAR™ analysis of customers and identified strategies for repositioning the product, altering targeting and messaging

Impact

  • Activities still ongoing, but RTA and Neurelis management are confident implementation of recommendations will considerably accelerate revenue growth